nLIGHT (LASR) CEO Scott Keeney sells 31,748 shares via 10b5-1 plan
Rhea-AI Filing Summary
nLIGHT, Inc. President and CEO Scott H. Keeney reported an option exercise and share sale of company stock. On January 6, 2026, he exercised options to acquire 31,748 shares of common stock at $1.15 per share, increasing his directly held stake. That same day, he sold 31,748 shares of common stock at a weighted average price of $37.51 per share in transactions ranging from $36.26 to $38.54 per share.
The sale was made under a pre-established Rule 10b5-1 trading plan adopted on June 12, 2025. After these transactions, Keeney directly beneficially owned 2,285,020 shares of nLIGHT common stock, including unvested restricted stock units. The option grant used for this exercise had been fully vested and exercisable since July 1, 2017 and is now shown with zero derivative securities remaining.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 0 | $0.00 | -- |
| Exercise | Common Stock | 31,748 | $1.15 | $37K |
| Sale | Common Stock | 31,748 | $37.51 | $1.19M |
Footnotes (1)
- Includes common stock owned and unvested restricted stock units. This reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. The reported transaction involves sale transactions from $36.26 to $38.54 per share. The weighted average price per share was $37.51. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price. This grant became fully vested and exercisable on July 1, 2017.
FAQ
Who is the insider in this nLIGHT (LASR) Form 4 filing and what is their role?
The insider is Scott H. Keeney, who serves as President, CEO, and a Director of nLIGHT, Inc. He filed the Form 4 as a single reporting person.
Did Scott Keeney exercise stock options in this nLIGHT Form 4?
Yes. On January 6, 2026, he exercised a stock option (right to buy) for 31,748 shares of common stock at an exercise price of $1.15 per share, using an option grant that had been fully vested and exercisable since July 1, 2017.
Was the nLIGHT (LASR) insider sale made under a Rule 10b5-1 trading plan?
Yes. The filing states that the reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Scott Keeney on June 12, 2025, indicating the trades were pre-arranged under that plan.
What happened to the stock option reported in the derivative securities table?
The derivative table shows a stock option with a $0.75 exercise price tied to 31,748 underlying shares. The footnotes explain that this grant became fully vested and exercisable on July 1, 2017. After the reported transaction, the number of derivative securities beneficially owned is listed as zero, indicating that grant has been fully used.